sondelbay
accord healthcare s.l.u. - teriparatid - osteoporose - calcium-homöostase - sondelbay is indicated in adults. behandlung von osteoporose bei postmenopausalen frauen und bei männern mit erhöhtem frakturrisiko. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. behandlung von osteoporose im zusammenhang mit anhaltenden systemischen glucocorticoid-therapie bei frauen und männern mit erhöhtem risiko für frakturen.
ebvallo
pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.
eladynos
theramex ireland limited - abaloparatide - osteoporosis, postmenopausal; osteoporosis - calcium-homöostase - behandlung von osteoporose bei postmenopausalen frauen mit erhöhtem frakturrisiko.
teriparatide sun
sun pharmaceutical industries europe b.v. - teriparatid - osteoporosis; osteoporosis, postmenopausal - calcium-homöostase - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.
vinorelbin accord 20 mg weichkapseln
accord healthcare b.v. - vinorelbintartrat -
vinorelbin accord 30 mg weichkapseln
accord healthcare b.v. - vinorelbintartrat -
kauliv
strides pharma (cyprus) limited - teriparatid - osteoporosis; osteoporosis, postmenopausal - calcium-homöostase - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.
paracodin - tropfen
teofarma srl - dihydrocodein thiocyanat - opium-alkaloide und deriv
paracodin tabletten
teofarma srl - dihydrocodein bitartrat - opium-alkaloide und deriv
cal-d-or 1000 mg/800 i.e. - kautabletten
cheplapharm arzneimittel gmbh - calciumcarbonat; colecalciferol - calcium, kombinationen mi